The U.S. solicitor general has urged the Supreme Court not to hear an appeal by Pfizer after a lower court decided the drugmaker could be sued in the U.S. for the deaths of Nigerian children that allegedly resulted from use of the antibiotic Trovan in a 1996 clinical trial.rnIn an amicus brief filed May 28, acting solicitor general Neal Katyal urged the court to deny Pfizer's petition for a writ of certiorari, saying there is no conflict in the courts on the issues presented.
展开▼
